Roche Hong Kong 羅氏香港

Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey. Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact. To provide the best care for each person we partner with many stakeholders and combine our strengths in Diagnostics and Pharma with data insights from the clinical practice. Roche has been named one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices for the thirteenth consecutive year. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit In Hong Kong & Macau, Roche employs more than 200 passionate people who, together, play a role in improving the lives of patients every day. Safety Reporting Disclaimer: This Page is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, please discuss with your treating Healthcare Professional and send the information to the Roche Patient Safety team via:(a) Email: hong_kong.drug_safety@roche.com or (b) Phone:+852 2733 4711.